A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Titel:
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Auteur:
Stopeck, Alison T. Unger, Joseph M. Rimsza, Lisa M. LeBlanc, Michael Farnsworth, Brent Iannone, Maria Glenn, Martha J. Fisher, Richard I. Miller, Thomas P.